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Currently available tools for multiplex bacterial genome engineer-
ing are optimized for a few laboratory model strains, demand ex-
tensive prior modification of the host strain, and lead to the
accumulation of numerous off-target modifications. Building on prior
development of multiplex automated genome engineering (MAGE),
our work addresses these problems in a single framework. Using a
dominant-negative mutant protein of the methyl-directed mismatch
repair (MMR) system, we achieved a transient suppression of DNA
repair in Escherichia coli, which is necessary for efficient oligonucle-
otide integration. By integrating all necessary components into a
broad-host vector, we developed a new workflow we term
pORTMAGE. It allows efficient modification of multiple loci, with-
out any observable off-target mutagenesis and prior modification
of the host genome. Because of the conserved nature of the
bacterial MMR system, pORTMAGE simultaneously allows genome
editing and mutant library generation in other biotechnologi-
cally and clinically relevant bacterial species. Finally, we applied
pORTMAGE to study a set of antibiotic resistance-conferring mu-
tations in Salmonella enterica and E. coli. Despite over 100 million
y of divergence between the two species, mutational effects
remained generally conserved. In sum, a single transformation of
a pORTMAGE plasmid allows bacterial species of interest to be-
come an efficient host for genome engineering. These advances
pave the way toward biotechnological and therapeutic applica-
tions. Finally, pORTMAGE allows systematic comparison of muta-
tional effects and epistasis across a wide range of bacterial species.
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Recent advances in genome engineering technologies aretransforming basic research and industrial biotechnology
through the previously unprecedented ability to engineer bio-
logical traits. Techniques incorporating zinc-finger nucleases,
transcription activator-like effector nucleases (TALENs), and
clustered regularly interspaced short palindromic repeats
(CRISPR) RNA-guided nucleases have allowed efficient targeted
modification of a host of model organisms (1), promising better
understanding of biological processes and more efficient produc-
tion of bioproducts. Although directed nucleases have widened
the range of bacterial species into which individual genomic
modifications can be introduced, there seems to be a technical
limit when it comes to using these techniques for simultaneous
modification of multiple loci (2, 3). Among others, multiplex
genome editing is required for explicit genotype-phenotype
mapping, as well as modification of protein complexes and bio-
synthetic pathways (4).
Currently, the only genome engineering method in bacteria that
enables rapid, automated and high-throughput genome editing is
multiplex automated genome engineering (MAGE) (5). MAGE
uses recombineering (6) to simultaneously incorporate multiple
single-strand DNA (ssDNA) oligonucleotides (oligos), and thereby
rapidly creates desired allele combinations and combinatorial ge-
nomic libraries. From accelerated optimization of biosynthetic
pathways (5, 7–9) to the construction of a so-called “genomically
recoded organism” (10–12), MAGE has allowed genome-engi-
neering endeavors of unparalleled complexity in Escherichia coli.
Functionality of ssDNA-mediated recombineering has been de-
scribed in various other species, including lactic acid bacteria (13),
Corynebacterium glutamicum (14), and Bacillus subtilis (15). How-
ever, portability remains seriously limited as these efforts require
prior optimization for each individual target species (Table S1).
Even in E. coli, for efficient and unbiased incorporation of
mutations by MAGE, extensive modifications—expression of the
λ Red recombinase enzymes, as well as inactivation of the native
methyl-directed mismatch repair (MMR) system—need to be
made to the host strain. Additionally, because of the inactivation
of the MMR machinery (16) necessary for MAGE, there is a
nearly two orders-of-magnitude increase in the background
mutation rate during the process, leading to the accumulation of
undesired, off-target mutations (17). These off-target mutations
could in turn interfere with the phenotypic effects of the engi-
neered modifications. Recently, we attempted to address this
issue by replacing wild-type mutL and mutS with heat-sensitive
mutants, and limiting the inactivation of MMR to a short period
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of the MAGE cycle. Although we managed to reduce the number
of off-target mutations by 85% (18), modification of the parental
strain was still a prerequisite. This issue was also recently
addressed by the so-called transient-mutator MAGE technique
(19), which allows for flexible, plasmid-based modification of
bacterial chromosomes. However, transient-mutator MAGE was
only demonstrated to work in E. coli, therefore portability across
species remained a formidable challenge.
Here, we developed a generalized strategy for bacterial genome
editing that overcomes these limitations of MAGE and expands
multiplex recombineering to other bacterial species. Key to this
process is the temperature-controlled expression of a dominant-
negative mutator allele of the E. coli MMR protein MutL (20),
enabling transient suppression of DNA repair during oligonucle-
otide integration. MutL is a component of the MutHLS complex
responsible for methyl-directed mismatch repair, acting to recruit
the MutH endonuclease to sites of DNA damage (21). Impor-
tantly, this particular mutator allele cannot be complemented by
the native MutL protein (20). Therefore, in contrast to traditional
MAGE, no prior disruption of the genomic copy is needed.
In this work, a set of plasmids (dubbed pORTMAGE) expressing
the λ Red recombinase enzymes, as well as the dominant-negative
mutator allele of MutL, all under the control of the cI857
temperature-sensitive repressor, were constructed. During each
MAGE cycle, expression of the synthetic operon is induced by a
single temporal temperature shift. Lowered MMR activity is only
necessary during a brief period of each MAGE cycle (i.e., during
allelic replacement). Because our protocol allows for rapid
switching between mutator and nonmutator states, it minimizes
the time the bacterial population spends susceptible to the ac-
cumulation of off-target mutations. As the standard MAGE pro-
tocol already incorporates a shift in temperature during induction
of the λ Red recombinase enzymes, the temperature shift required
during pORTMAGE is entirely compatible with the established
procedure (5).
Additionally, because of the highly conserved nature of MutL
(22), expression of this E. coli mutL allele can suppress mismatch
repair in distant relatives of E. coli, diverged from it ∼100–200
million y ago (23). Thus, pORTMAGE simultaneously allows
genome editing and mutant library generation in several bio-
technologically and clinically relevant bacterial species. As a
proof-of-concept study, we demonstrate that pORTMAGE is a
valuable tool to study clinically relevant issues, such as the
phenotypic impact of antibiotic resistance conferring mutations
across bacterial species.
Results
Characterization of the MutL E32K Dominant-Negative Mutator. First,
we characterized the effect of the previously described (20)
dominant-negative mutator allele MutL E32K on the function-
ality of the MMR system in wild-type E. coli K-12 MG1655.
Using standard techniques (SI Materials and Methods), we cloned
the mutant allele into the inducible expression vector pZA31tetR
(24, 25). Induced expression resulted in an over 30-fold increase in
mutation rate in the wild-type as measured by a rifampicin re-
sistance assay and subsequent fluctuation analysis (26) (Fig. S1).
This approached the mutation rate of the MG1655ΔmutS deletion
strain lacking functional MMR machinery, and showed that the
wild-type copy of MutL was not able to suppress the effect of the
dominant-negative mutant allele. We conclude that this construct
enables controlled disruption of the MMR machinery from an
extrachromosomal expression system.
pORTMAGE Allows Highly Efficient and Unbiased Allelic Replacement
in E. coli.We rationalized that temperature-controlled expression
of a dominant-negative mutator allele of MutL (18) would allow
a transient switch from a nonmutator to mutator phenotype of
the host cell. At nonpermissive temperatures (30–34 °C), the
mutant protein is not expressed, allowing the native MMR sys-
tem to function properly, thus limiting the number of back-
ground mutations to wild-type level. Moreover, as the particular
E32K mutator allele cannot be complemented by the native
MutL protein, no disruption of the genomic copy is needed.
For ease of use, all required genetic parts for MAGE were
assembled on a single plasmid with a broad host range origin of
replication (pBBR1) (27), resulting in the pORTMAGE plasmid
(Fig. 1). In this arrangement, expression of the mutL E32K gene,
as well as the three λ Red recombinase enzymes (exo, bet, and
gam) were under the control of the cI857 temperature-sensitive λ
repressor. Quantitative real-time RT-PCR (qPCR) testing showed
that temperature induced transcription of the operon resulted in a
320- to 770-fold increase in mutL expression (Fig. S2).
To investigate the effect of the expression of the dominant-
negative MutL allele on allelic replacement frequency of ssDNA
oligos, we used a previously characterized test system (28). We
introduced a diverse set of single-base pair mismatches (A:A, G:G,
T:T, G:A, G:T, C:A, and C:T) at specific genomic locations within
lacZ. Because these mutations introduce premature stop codons
within lacZ, the frequency of allelic replacement could be easily
measured by a colorimetric assay (SI Materials and Methods). Two
separate oligos were used to generate a G:A mismatch at different
positions to show that repair of a specific mismatch type is also
context-dependent, as demonstrated previously (28). We found
that in all cases, pORTMAGE allowed highly efficient and un-
biased oligo incorporation, comparable to the capacity of the
traditional MAGE protocol on a mismatch repair knockout
background (18, 28). Indeed, allelic replacement frequency
greater than 20% was observed in all instances, even in the cases
of mismatches that are otherwise well recognized and almost
completely corrected by the wild-type MMR system (Fig. S3).
Efficient Multiplex Genome Editing Is Coupled with Low Off-Target
Mutation Rate. Using pORTMAGE, we carried out multiplex ge-
nome editing to investigate allelic replacement frequency and off-
target mutagenesis simultaneously. Three strains were compared: a
Fig. 1. General map of the pORTMAGE plasmid. Expression of the mutL
E32K gene [along with the three λ Red recombinase enzymes (exo, bet, and
gam)] is controlled by the cI857 temperature-sensitive λ repressor.
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mutator strain carrying the control pSIM8 plasmid (27) expressing
the λ Red recombinases [ΔmutS(pSIM8)], the wild-type nonmutator
strain carrying pORTMAGE [MG1655(pORTMAGE)], and the
wild-type strain carrying the control plasmid [MG1655(pSIM8)].
In 24 cycles of MAGE, six different loci were subsequently tar-
geted (four cycles each). These loci are widely distributed across the
genome and were targeted by oligos that introduce various types of
mismatches into them (see ref. 18 for details). Clones carrying a
particular modification were verified by capillary sequencing, fol-
lowed by MAGE cycles targeting the next locus. Allelic replacement
frequencies were determined at each locus either by colorimetric
assay or allele-specific PCR (SI Materials and Methods).
As expected, allelic replacement frequency with MG1655
(pSIM8) was very low in all cases. MG1655(pORTMAGE) gen-
erally displayed a high level of replacement, approaching the
values observed with traditional MAGE using ΔmutS(pSIM8)
(Table 1). In some cases (e.g., araB T50A and cycA AA139TG),
the values observed with MG1655(pORTMAGE) were signifi-
cantly lower than with ΔmutS(pSIM8) but still over an order-
of-magnitude higher than that of MG1655(pSIM8).
Next, we investigated the accumulation of off-target muta-
tions. After 24 cycles of MAGE, we selected one independently
edited clone each derived from MG1655(pORTMAGE), ΔmutS
(pSIM8), and MG1655(pSIM8), respectively. To infer the number
of off-target mutations, the genomes of the starting and the
MAGEderived clones were sequenced using the IonTorrent PGM
system. MG1655(pSIM8) accumulated only two off-target muta-
tions. In sharp contrast, ΔmutS(pSIM8) carried 84 different off-
target genomic mutations, a figure that is in line with previous
reports (17, 18). Remarkably, we failed to find any off-target
mutation in MG1655(pORTMAGE). For a complete list of all
off-target mutations, see Dataset S1.
Taken together, these results demonstrate that high allelic
replacement frequency in pORTMAGE is coupled with an ex-
ceptionally low off-target mutation rate.
pORTMAGE Allows Rapid Genome Editing Across a Range of Bacterial
Species. We first tested the impact of the dominant mutL allele
on mutation rates in several enterobacterial species with bio-
technological or clinical relevance. We selected as models the
clinically important Salmonella enterica serovar Typhimurium (strain
LT2), the fish pathogen Edwardsiella tarda (strain ATCC15947), the
opportunistic pathogen Escherichia hermanii (strain HNCMB35034),
as well as the biotechnologically relevant organisms Citrobacter
freundii (strain ATCC8090), and E. coli BL21(DE3). Phylogenetic
comparison of MutL sequences (Fig. S4) showed that glutamic acid
is conserved in all investigated species at the position of the mutation
in the E. coli dominant-negative allele E32K (22). We therefore
assumed that the mutant allele would have similar phenotypic effect
in these species. In agreement with expectation, overproduction of
the E. coli mutant MutL showed similar, at least an order-of-
magnitude increase in mutation rates in all other investigated
species (Fig. S5), indicating the feasibility of the pORTMAGE
strategy in other species.
Next, we compared the efficacy of pORTMAGE in E. coli
K-12 MG1655, and distant relatives S. enterica and C. freundii. To
broaden the potential applications of pORTMAGE, we engineered
three modified pORTMAGE plasmids with elevated MutL ex-
pression and different antibiotic markers (SI Materials and
Methods). To characterize the performance of pORTMAGE in a
uniform manner across species, we constructed a landing pad
sequence integrated into the host genome, and used it as the
target sequence (Fig. 2A; see also Dataset S2 for all bacterial
strains used in the study and the corresponding genotype infor-
mation, and Dataset S3 for the complete nucleotide sequence). A
set of five oligos (90 nucleotides in length each), introducing all
possible single-base mismatches at given positions were designed.
Each oligo carried a degenerate base at one of four specific po-
sitions representing all four nucleotides, plus an additional oligo to
assay positional differences of the same target nucleotide. One
MAGE cycle was carried out using these oligos pooled together.
As in the previous section, we compared the performances of
the wild-type strain carrying the control plasmid, the wild-type
nonmutator strain carrying a pORTMAGE plasmid, and the
mutator ΔmutS strain carrying the control pSIM8 plasmid. To
measure allelic replacement frequencies within the population
after one MAGE cycle, we performed deep-sequencing of the
targeted landing pad sequence using an Illumina MiSeq set-up.
Replacement efficiency in the wild-type control carrying
pSIM8 varied substantially across the three investigated species
(Fig. 2 B–D), suggesting natural variation in mismatch repair. In
addition, mutations introducing the same mismatch at different
positions showed a difference in some cases compared with each
other, indicating a context dependency of the efficiency of mis-
match repair. Despite these differences, allelic replacement
frequency with pORTMAGE was in several cases two orders-of-
magnitude higher and largely unbiased in all three species
compared with the wild-type control (Fig. 2 B–D). Moreover, in
E. coli K-12 MG1655 (Fig. 2B) and S. enterica (Fig. 2C), allelic
replacement frequencies with pORTMAGE approached the
values obtained with ΔmutS for all incorporated mismatch types.
In C. freundii, the pORTMAGE plasmid showed the same robust
performance as in E. coli and S. enterica (Fig. 2D).
Finally, we investigated the impact of pORTMAGE on re-
placement efficiency using an established protocol (cos-MAGE)
that includes enrichment of the desired genetic modifications
using a selectable marker gene (7). Such a coselection procedure
is biotechnologically relevant, as it aids incorporation of hard-
to-engineer genomic modifications. The landing pad sequence
was designed to contain an inactivated cat gene. Accordingly, a
single MAGE cycle was carried out using an oligo repairing the
inactivated cat gene, followed by selection for the appropriate
genetic marker (chloramphenicol resistance). We found that
pORTMAGE substantially increased allelic replacement fre-
quencies in all investigated species (Fig. S6).
pORTMAGE Allows Efficient Generation of Mutant Libraries in Various
Bacterial Species. Next, using pORTMAGE, we introduced se-
quence diversity at specific genetic loci. We randomized six indi-
vidual bases within the asnA gene in three species (E. coli, S. enterica,
and C. freundii). Using organism-specific 90-base oligos carrying
six randomized positions, we carried out five cycles of MAGE.
Table 1. Allelic replacement frequency of all six used oligos in MG1655(pSIM8), ΔmutS(pSIM8),
and MG1655(pORTMAGE) after four genome editing cycles each
Strain
Allelic replacement frequency (%)
lacZ A652T malK C252G araB T50A hisB C166T rpsL A128G cycA AA139TG
MG1655(pORTMAGE) 54.58 61.56 39.76 22.92 33.76 22.92
ΔmutS(pSIM8) 51.32 60.23 62.87 39.58 38.91 41.67
MG1655(pSIM8) 45.31 51.82 1.56 <0.1 0.72 1.04
Each oligo name consists of the targeted gene and the introduced nucleotide modification.
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Genomic DNA was isolated, the target region was amplified by
PCR, and finally, the fragments were subjected to Illumina deep-
sequencing. In all three species (Fig. S7), allelic replacement fre-
quencies with pORTMAGE were at least an order-of-magnitude
higher at all six positions, compared with the frequencies obtained
with the control pSIM8 plasmid. Additionally, pORTMAGE sub-
stantially reduced the biases in the incorporation frequency of
certain nucleotides, allowing for a more uniform distribution of the
mutants in the population. Using pORTMAGE, we obtained a
bias-free mutant library at the target locus for each species (Fig. S7),
suggesting that all possible ∼4,000 variants were represented at
a reasonable quantity.
Application of pORTMAGE to Study Antibiotic Resistance in S. enterica.
It has long been suggested that because of the prevalence of
epistatic interactions, mutations beneficial in one genetic back-
ground are frequently neutral or even deleterious in another
(29). This issue is especially relevant in the context of antibiotic
resistance, as this phenomenon could contribute to the observed
differences in the molecular mechanisms underlying antibiotic
resistance in related microbial species. Better understanding of
this problem demands genome editing applicable in a range of
species. Here, we demonstrate that pORTMAGE is an excep-
tionally effective tool for studying the phenotypic effects of
individual mutations.
We introduced 10 mutations individually into the genomes of
S. enterica and E. coli (for the list of mutations, see Table 2).
These mutations have previously been detected in an experimental
evolution study (30) and confer resistance to one or multiple
antibiotics. The corresponding genes are not only clinically rel-
evant, but also show 79–99% sequence identities between the
two species. The nucleotide sequences subjected to editing by
pORTMAGE were fully conserved in most cases and were mu-
tated to the same residue in all cases.
The workflow consisted of the introduction of each mutation
into the receiver strain by a single MAGE cycle, selection of the
desired mutation by high-resolution melting (HRM) analysis, and
subsequent confirmation of the mutations by capillary-sequencing.
The complete workflow took as few as 4 d for completion. As a
measure of the effect of each individual mutation, the sensitivity of
each mutant was measured against the antibiotic that it arose
against during the course of laboratory evolution (30). Using a
well-established protocol (31), the minimum inhibitory concen-
tration (MIC) value of each antibiotic against the given mutant
was determined compared with the wild-type strain (relative MIC
value = MIC of the mutant/MIC of the wild-type). Finally, we
compared the relative MIC changes conferred by each individual
mutation in S. enterica and E. coli (Table 2 and Fig. S8).
We found that despite over 100 million y of divergence between
the two species, mutational effects remained generally conserved. In
most cases, the investigated mutations resulted in a small, but sig-
nificant decline in antibiotic susceptibilities in both species (Table 2).
There were a few notable exceptions to this trend. For example,
the S83L amino acid substitution in the major target protein
(GyrA) confers resistance to nalidixic acid and other gyrase in-
hibitor drugs (32). The very same mutation is regularly observed in
Fig. 2. (A) General map of the landing pad sequence inserted into the various strains. The green region represents a target sequence for allelic replacement by a set
of five oligos shown in the targeting box. Degenerate bases are shown for each oligo in red. The cat gene conferring resistance to chloramphenicol was included in the
landing pad to allow for cos-MAGE to be performed (see SI Materials and Methods for details). Allelic replacement frequency of the various test oligonucleotides
targeting the tetR landing pad sequence in (B) E. coli K-12 MG1655, (C) TS616 derivative of S. enterica serovar Typhimurium LT2, and (D) C. freundii (strain ATCC8090).
The values are the means of two independent measurements using Illumina deep-sequencing; error bars represent SEMs. An asterisk denotes oligos generating
the same mismatch as another oligo to demonstrate context dependency of allelic replacement. DmutS denotes deletion of the mutS gene.
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antibiotic-resistant laboratory and clinical E. coli strains (30, 33).
Surprisingly, we found that the level of resistance conferred by
S83L is at least six-times higher in S. enterica than in E. coli (Table
2). Another interesting case is MarR, a central regulator of the Mar
(multiple anbiotic resistance) regulon that coordinates the expres-
sion of a global network of at least 80 chromosomal genes (34). The
Val84Glu mutation in this gene confers a twofold decrease in
ampicillin susceptibility in E. coli, whereas mutating to the same
residue barely had any phenotypic effect in S. enterica (Table 2).
Clearly, the genetic and molecular mechanisms underlying these
differences in mutational effects between species deserve future
investigations. Our main aim here was to demonstrate how
unique pORTMAGE is to study these clinically important issues.
Discussion
Among the currently available bacterial genome-editing tools, oli-
gonucleotide-mediated recombineering is probably the most cost-
effective and versatile choice (Table S1). Bacterial recombineering
has been optimized toward multiplexing and automation, resulting in
MAGE (5). Additionally, oligonucleotides can now be designed (35)
and synthesized (36) with great ease at large quantities, allowing for
genome-engineering undertakings of unprecedented complexity
(10–12). However, multiplex bacterial genome engineering has been
optimized for a few laboratory model strains, demands extensive
prior modification of the host strain, and leads to the accumu-
lation of numerous off-target modifications (Table S1). Accu-
mulation of unwanted mutations in the targeted cells can mask
the effect of the intentionally introduced modifications. Fur-
thermore, for inactivation of the MMR system, the host has to
be modified beforehand, greatly limiting the ease of use and
narrowing the applicable range of organisms. Although a method
expanding multiplex genome editing has recently been described
[MuGENT (37)], it is applicable only to naturally transformable
bacteria (for other potential limitations, see Table S1). Building on
prior works, our study addresses the above mentioned three major
problems—ease of use, off-target mutagenesis, and portability
across species—in a single framework.
We developed pORTMAGE, an all-in-one plasmid set easily
applicable to a range of Gram-negative bacterial species. The main
results are as follows. First, transient expression of a dominant
mutator allele of the MutL MMR protein allows for a controllable
switch between mutator and nonmutator phenotype in a range of
clinically and biotechnologically relevant species. Second, by imple-
menting this advance, highly efficient and precise allelic replacement
was achieved in selected enterobacterial species. Third, efficient
multiplex genome editing was coupled with low off-target mutation
rate. Fourth, pORTMAGE allowed rapid generation of large, un-
biased sequence libraries at desired positions in these species.
Finally, we used pORTMAGE to introduce 10 antibiotic-
resistance mutations into the genomes of S. enterica and E. coli,
two species that diverged from each other more than 100 million
y ago. The complete workflow took 4 d for completion. To the
best of our knowledge, this is a significant improvement over
traditional gene-editing protocols applicable to S. enterica, as
they are either slow, have relatively low replacement efficiency,
or are prone to off-target mutagenesis. These advances allowed
us to address the extent of conservation of the molecular
mechanisms underlying antibiotic resistance. We found that de-
spite over 100 million y of divergence between the two species,
mutational effects remained generally conserved. In most cases,
the investigated mutations resulted in a small, but significant de-
cline in antibiotic susceptibilities in both species. However, the
phenotypic effects of certain canonical mutations varied exten-
sively between the two species. For example, the level of resistance
conferred by the canonical S83L mutation in gyrase A is at least
six-times higher in S. enterica than in E. coli (Table 2). One pos-
sible interpretation of this result is that epistatic interactions within
and across genes shape the antibiotic resistance profile. Clearly,
pORTMAGE facilitates future studies in this direction.
In all, by combining efficient allelic replacement with low
background mutation rate and portability, pORTMAGE offers a
convenient tool to refactor complex cellular traits and system-
atically engineer metabolic pathways in a diverse set of entero-
bacterial species. pORTMAGE also paves the way toward
exploring mutational effects and epistasis, which could potentially
be exploited for the development of novel antimicrobial strategies.
However, pORTMAGE has two potential limitations
(Table S1). First, an important unresolved issue is the extent to
which the applicability of pORTMAGE demands sequence
similarity of MutL between the host organism and E. coli. We
suspect that pORTMAGE does not require high sequence
conservation, as long as the functional role of MutL in the
mismatch-repair system remains unchanged. Indeed, despite
substantial differences in MutL sequences between Pseudomonas
aeruginosa and E. coli, the P. aeruginosa copy is able to com-
plement that of E. coli (38). In fact, even the human mismatch-
repair protein MutL homolog 1 (hMLH1) functionally interacts
with the E. coli MMR machinery and was able to induce a
dominant mutator state in E. coli (39). Because inactivation of
the MMR machinery greatly improves allele replacement effi-
ciency in organisms ranging from yeast (40) to human cell lines
(41, 42), pORTMAGE could inspire future development of gen-
eral genome editing tools.
Another potential problem is that, similarly to other recombi-
nase-based genome-editing tools, pORTMAGE heavily relies on
the use of specific enzymes and expression vectors. The expanding
repertoire of characterized recombinases and expression systems
(15, 43–46) will presumably allow for broad use in the near future.
We anticipate that our work will have implications for clinical
and biotechnological problems as well. For example, pORTMAGE
may be used in engineering of attenuated bacterial pathogens
for vaccine development (47). It may be also useful for metabolic
engineering attempts in previously untapped species. For example,
C. freundii is an efficient host for the production of valuable bio-
products (48), but optimization of metabolic pathways remained
challenging in this species. Because C. freundii is amenable to
pORTMAGE, we expect rapid future development in this area.
Other species, such as environmental Pseudomonas strains, have
great potential to serve as chassis for industrial biotechnology (49)
but are thus far lacking in robust techniques allowing for efficient
multiplex genome editing. Finally, pORTMAGE could also open
a new avenue of research in diverse fields such as functional
Table 2. Relative MIC values of mutant strains of E. coli and
S. enterica
Gene Mutation Antibiotic
E. coli
relative MIC
S. enterica
relative MIC
mprA Arg110Leu NIT 1.20 1.73
marR Val84Glu AMP 2.20 1.15
soxR Leu139* ERY 2.31 1.73
phoQ Gly384Cys NIT 1.20 0.83
trkH Thr350Lys STR 3.18 1.59
gyrA Ser83Leu CPR 16.00 16.00
gyrA Ser83Leu NAL 97.66 610.35
fis Thr70Pro ERY 1.44 1.44
acrR Gln78* ERY 1.20 1.00
ompC Met1 NIT 1.20 1.20
ycbZ Ser438Arg ERY 1.23 1.51
The sensitivity of each mutant strain was measured against the antibiotic
against which the specific mutation formed during laboratory adaptation
(30). The measured MIC for each strain was then compared with the MIC of
the wild-type strain, resulting in the relative MIC value. The antibiotic abbre-
viations are as follows: AMP, ampicillin; CPR, ciprofloxacin; ERY, erythromycin;
NAL, nalidixic acid; NIT, nitrofurantoin; STR, streptomycin.
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genomics and evolutionary biology (50). To our knowledge, for
the first time, pORTMAGE allows systematic comparison of
mutational effects and epistasis across a wide range of bacterial
species.
Materials and Methods
Detailed descriptions of the methodology, including (i) strains and reagents,
(ii) oligonucleotides, (iii) plasmid construction, (iv) pORTMAGE cycling pro-
tocol, (v) whole-genome resequencing, (vi) high-throughput sequencing for
allelic replacement frequency measurement, (vii) integration of landing pad
sequence into host strains, (viii) construction of antibiotic resistance associated
mutants, (ix) MIC measurement, (x) qPCR measurement, and (xi) mutation
rate measurement can be found in SI Materials and Methods.
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